PV pharm branch, vendor, cage 0U9U0
Ended Awarded Last action
- Contract number
- SPE2D826F0CYH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $113,024
Award facts
- Contract value 100% obligated
- $113,023.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $113,023.56 by the Defense Logistics Agency's Medical Supply Chain on January 12, 2026, with completion expected by January 13, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a task order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. The parent company, Cencora, Inc. (doing business as AmerisourceBergen), holds a significant $999,999,999.00 IDC through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide, enabling the delivery of specialty medications, brand-name and generic drugs, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains.
This delivery order exemplifies AmerisourceBergen's role as a critical federal vendor serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's consistent receipt of non-set-aside, competitively awarded contracts across a broad spectrum of pharmaceutical products—ranging from routine medications to specialized treatments—demonstrates its established capability to meet federal medical procurement requirements. As the DLA Troop Support prepares to establish its next-generation Pharmaceutical Prime Vendor Global Program contracts with anticipated multiple awards across separate regions, AmerisourceBergen's existing performance history positions it as a key stakeholder in federal pharmaceutical supply chains supporting military and veteran healthcare systems globally.
Quick answers
Who was awarded contract SPE2D826F0CYH?
SPE2D826F0CYH was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on January 12, 2026.
How much is contract SPE2D826F0CYH worth?
The government has obligated $113,024 on SPE2D826F0CYH.
Is contract SPE2D826F0CYH an order under another contract?
Yes. SPE2D826F0CYH is a delivery order under SPE2DX22D0129, an indefinite delivery contract.
Was contract SPE2D826F0CYH competed?
The extent of competition for SPE2D826F0CYH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award